[go: up one dir, main page]

DE69927600D1 - Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung - Google Patents

Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung

Info

Publication number
DE69927600D1
DE69927600D1 DE69927600T DE69927600T DE69927600D1 DE 69927600 D1 DE69927600 D1 DE 69927600D1 DE 69927600 T DE69927600 T DE 69927600T DE 69927600 T DE69927600 T DE 69927600T DE 69927600 D1 DE69927600 D1 DE 69927600D1
Authority
DE
Germany
Prior art keywords
tissue constructs
biotechnically
production
cultured
matrix components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927600T
Other languages
English (en)
Other versions
DE69927600T2 (de
Inventor
P Murphy
Vincent Ronfard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organogenesis Inc
Original Assignee
Organogenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organogenesis Inc filed Critical Organogenesis Inc
Publication of DE69927600D1 publication Critical patent/DE69927600D1/de
Application granted granted Critical
Publication of DE69927600T2 publication Critical patent/DE69927600T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69927600T 1998-11-19 1999-11-19 Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung Expired - Lifetime DE69927600T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10924798P 1998-11-19 1998-11-19
US109247P 1998-11-19
US33963299A 1999-06-24 1999-06-24
US339632 1999-06-24
PCT/US1999/027505 WO2000029553A1 (en) 1998-11-19 1999-11-19 Bioengineered tissue constructs and methods for producing and using them

Publications (2)

Publication Number Publication Date
DE69927600D1 true DE69927600D1 (de) 2005-11-10
DE69927600T2 DE69927600T2 (de) 2006-07-06

Family

ID=26806787

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927600T Expired - Lifetime DE69927600T2 (de) 1998-11-19 1999-11-19 Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung

Country Status (15)

Country Link
US (2) US7824913B2 (de)
EP (3) EP1612265B1 (de)
JP (2) JP2002530069A (de)
CN (2) CN1333818A (de)
AT (1) ATE305967T1 (de)
AU (3) AU769637B2 (de)
BR (1) BR9915476A (de)
CA (1) CA2351396C (de)
DE (1) DE69927600T2 (de)
DK (1) DK1131410T3 (de)
ES (2) ES2402739T3 (de)
HK (1) HK1040740A1 (de)
IL (1) IL143243A0 (de)
PT (1) PT1612265E (de)
WO (1) WO2000029553A1 (de)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2351396C (en) * 1998-11-19 2012-08-14 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20020081732A1 (en) * 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US20040018226A1 (en) * 1999-02-25 2004-01-29 Wnek Gary E. Electroprocessing of materials useful in drug delivery and cell encapsulation
KR20030043928A (ko) * 2000-08-08 2003-06-02 바이오아미드 인코포레이티드 조직 조작된 모발용 지지체
CA2457162A1 (en) * 2000-09-01 2002-03-07 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed fibrin-based matrices and tissues
MXPA03002415A (es) * 2000-09-18 2004-07-08 Organogenesis Inc Metodo para tratar a un paciente que utiliza una construccion de tejido conectivo cultivado.
EP1832300A3 (de) * 2000-09-18 2008-02-27 Organogenesis Inc. Verfahren zur Behandlung eines Patienten unter Verwendung eines kultivierten Bindegewebekonstrukts
WO2002025272A1 (en) * 2000-09-21 2002-03-28 Shiseido Company, Ltd. Method of evaluating the degree of maturity of corneous cells
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
JP4822635B2 (ja) * 2001-09-05 2011-11-24 株式会社 資生堂 人工毛球部及びその製造方法、並びに、人工毛球部を用いた薬剤の評価方法
KR100777993B1 (ko) * 2001-10-15 2007-11-28 도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 정상 재생조직의 형성방법과 정상 재생조직 및 감수성등의 검정방법
FR2833610B1 (fr) * 2001-12-14 2007-01-26 Natural Implant Construits cellulaires cultives in vitro, preparation et utilisations
DE10162814B4 (de) * 2001-12-19 2005-06-23 Henkel Kgaa Rekonstruiertes Haarfollikelmodell
US20050089512A1 (en) * 2001-12-19 2005-04-28 Kordula Schlotmann Skin/hair equivalent with reconstructed papillae
DE10220472A1 (de) * 2002-05-07 2003-11-27 Hans-Guenther Machens Bioartifizielle Haut
CA2532418C (en) * 2002-07-16 2014-07-15 Biogentis Inc. Method for preparing engineered tissue
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
WO2005002601A1 (en) 2003-06-25 2005-01-13 Badylak Stephen F Conditioned matrix compositions for tissue restoration
US8043614B2 (en) 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
EP1688484B1 (de) * 2003-10-06 2017-06-28 Shiseido Company, Ltd. Verfahren zur herstellung einer haarpapillazellpräparation, zusammensetzung und verfahren zur regenerierung von haarfollikel sowie tier mit regeneriertem haarfollikel
JP2005218445A (ja) * 2004-01-09 2005-08-18 Technology Seed Incubation Co Ltd 培養皮膚細胞とこれを原料として用いた移植用材及び遺伝子解析用材並びに培養皮膚細胞の製造方法
WO2006048783A2 (en) 2004-03-09 2006-05-11 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
EP1727893B1 (de) * 2004-03-09 2012-12-12 Jan-Eric W. Ahlfors Autogenische lebende gerüste und lebende gewebematrizen: verfahren und ihre verwendungen
US7597885B2 (en) 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
US7597687B2 (en) 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US8796015B2 (en) 2004-11-09 2014-08-05 Proxy Biomedical Limited Tissue scaffold
AU2006247317B2 (en) * 2005-05-16 2012-04-05 Purdue Research Foundation Engineered extracellular matrices
EP1945757B1 (de) * 2005-10-17 2017-12-06 Aderans Research Institute, Inc. Methode zur verteilung von haarfollikel-vorläuferzellen auf der haut
SG184751A1 (en) 2005-10-26 2012-10-30 Jan-Eric W Ahlfors Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
US20070148138A1 (en) 2005-11-22 2007-06-28 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
MX2008010137A (es) * 2006-02-07 2009-01-07 Organogenesis Inc Construcciones de tejido diseñadas por bioingenieria y sus usos cardiacos.
EP1986731A4 (de) * 2006-02-09 2012-11-07 Aderans Res Inst Inc Vorrichtung und verfahren zur abgabe von flüssigkeit und material an ein subjekt
JP5386180B2 (ja) 2006-02-28 2014-01-15 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク 真皮細胞のコンパクト凝集のための方法
AU2007223276B2 (en) * 2006-03-03 2012-12-20 Organogenesis, Inc. Oral tissue regeneration and repair
GB0605450D0 (en) * 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
US20070269476A1 (en) * 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
GB2453452B (en) * 2006-05-16 2010-12-01 Purdue Research Foundation Three dimensional purified collagen matrices
FR2903702B1 (fr) 2006-07-13 2012-10-19 Oreal Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
AU2007297611B2 (en) 2006-09-21 2013-02-07 Purdue Research Foundation Collagen preparation and method of isolation
WO2008060822A2 (en) * 2006-10-20 2008-05-22 Keracure, Inc. Devices with cells cultured on flexible supports
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
EP2079490B1 (de) * 2006-10-23 2012-08-29 Cook Biotech Incorporated Aufbereitete ecm-materialien mit erweiterten komponentenprofilen
WO2008105454A1 (ja) 2007-02-28 2008-09-04 Senju Pharmaceutical Co., Ltd. ラクリチン高発現細胞
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
US20100278798A1 (en) * 2007-09-27 2010-11-04 The Trustees Of Columbia University In The City Of New York Methods and systems for forming biocompatible materials
MX2010005791A (es) * 2007-11-28 2010-08-10 Organogenesis Inc Construcciones de tejido hechas mediante bio-ingenieria y metodos para produccion y uso.
US9867905B2 (en) * 2007-12-10 2018-01-16 Purdue Research Foundation Collagen-based matrices with stem cells
US8613776B2 (en) * 2007-12-27 2013-12-24 The Trustees Of Columbia University In The City Of New York Systems and methods for forming patterned extracellular matrix materials
CA2714387C (en) * 2008-01-30 2018-06-19 Histogen, Inc. Extracellular matrix compositions
US8524494B2 (en) 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
WO2010056378A2 (en) 2008-11-14 2010-05-20 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
US20100166822A1 (en) * 2008-12-31 2010-07-01 Howmedica Osteonics Corp. Adhesive cartilage implant
KR101753797B1 (ko) 2009-06-04 2017-07-04 더 제너럴 하스피탈 코포레이션 생인공 폐
US8986377B2 (en) * 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US20110046639A1 (en) * 2009-08-24 2011-02-24 Konstantinos Giotis Method of direct hair implantation
KR20120114282A (ko) * 2009-12-04 2012-10-16 유클리드 시스템스 코포레이션 황반변성, 당뇨망막병증 및 당뇨 황반부종의 예방 및 치료를 위한 조성물 및 방법
EP2524034A1 (de) * 2010-01-14 2012-11-21 Organogenesis, Inc. Biotechnologisch hergestellte gewebekonstrukte sowie verfahren zu ihrer herstellung und verwendung
WO2011133599A2 (en) * 2010-04-20 2011-10-27 International Stem Cell Corporation Physiological methods for isolation of high purity cell populations
ES2667532T3 (es) * 2010-06-18 2018-05-11 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Neogénesis del folículo piloso
FR2976001B1 (fr) 2011-05-30 2014-10-31 Oreal Modele de cuir chevelu reconstruit et procede de screening de molecules actives
GB201112922D0 (en) * 2011-07-27 2011-09-14 Univ Durham Micro-organ
US20130190210A1 (en) * 2011-09-12 2013-07-25 Organovo, Inc. Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same
PH12014501019A1 (en) * 2011-11-11 2014-06-16 Essential Pharmaceuticals Llc Kit comprising serum replacement and labile factors
ES2596522T3 (es) 2012-01-13 2017-01-10 Lifecell Corporation Prótesis mamarias y métodos de fabricación de prótesis mamarias
HK1205707A1 (en) * 2012-03-07 2015-12-24 Fibrocell Technologies, Inc. Topical dermal formulations and methods of personalized treatment of skin
USD690004S1 (en) 2012-03-16 2013-09-17 Aderans Research Institute, Inc. Holder for a device for delivering cellular material and physiologic fluids
US9877822B2 (en) 2012-04-24 2018-01-30 Biostage, Inc. Engineered tissue scaffolds and supports therefor
ES2647979T3 (es) 2012-06-21 2017-12-27 Lifecell Corporation Prótesis implantable que tiene fijaciones tisulares acelulares
US9956072B2 (en) 2012-10-04 2018-05-01 Lifecell Corporation Surgical template and delivery device
DE102012223061A1 (de) 2012-12-13 2014-06-18 Henkel Ag & Co. Kgaa Altershautmodell
US11284987B2 (en) 2013-01-09 2022-03-29 Biostage, Inc. Synthetic scaffolds
RU2019100033A (ru) 2013-02-12 2019-02-12 Репликэл Лайф Сайенсиз Инк. Композиции и способы для лечения и восстановления сухожилий
CA2910328C (en) 2013-05-03 2019-10-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
CN103497892B (zh) * 2013-09-03 2015-12-02 中山大学 一种细胞培养基材及其制备方法和应用
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
TW201538730A (zh) 2014-02-12 2015-10-16 Replicel Life Sciences Inc 用於治療骨骼、關節及軟骨之組合物及方法
CN117694335A (zh) 2014-03-14 2024-03-15 通用医疗公司 肺生物反应器
JP6218238B2 (ja) * 2014-07-10 2017-10-25 国立大学法人大阪大学 人工皮膚及びその製造方法
EP4548939A3 (de) 2014-08-27 2025-08-06 Purdue Research Foundation Abgabesysteme für therapeutikum auf kollagenbasis
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
WO2016186803A1 (en) 2015-05-15 2016-11-24 Lifecell Corporation Tissue matrices for plastic surgery
EP3313976A4 (de) * 2015-06-25 2019-02-20 Auckland Uniservices Limited Gewebekulturvorrichtung und -verfahren
WO2017024090A1 (en) * 2015-08-06 2017-02-09 The Johns Hopkins University Tissue-derived scaffolds for corneal reconstruction
EP3337427A1 (de) 2015-08-21 2018-06-27 Lifecell Corporation Brustbehandlungsvorrichtung
DE102015119880B4 (de) * 2015-11-17 2018-05-24 Technische Universität Berlin Verfahren zur Herstellung von Haarfollikeln und de novo Papillen sowie deren Verwendung für in vitro Tests und in vivo Implantate
CN109689071B (zh) 2016-05-16 2023-05-30 通用医疗公司 肺上皮工程中的人气道干细胞
US10624992B2 (en) 2016-05-16 2020-04-21 The General Hospital Corporation Human airway stem cells in lung epithelial engineering
DK3506854T3 (da) 2016-08-31 2020-11-23 Lifecell Corp Brystbehandlingsindretning
MX380950B (es) * 2016-09-23 2025-03-12 Univ Mexico Nac Autonoma Metodo para preparar un suplemento a partir de cultivos de celulas mesenquimales de gelatina de wharton y usos del mismo.
CN106544281B (zh) * 2016-12-07 2019-07-02 哈尔滨工业大学 一种基于蛋白质和多糖构筑生物体保护层的制备方法
WO2018144496A1 (en) 2017-01-31 2018-08-09 Geniphys, Llc Methods and compositions for matrix preparation
US11739291B2 (en) 2017-04-25 2023-08-29 Purdue Research Foundation 3-dimensional (3D) tissue-engineered muscle for tissue restoration
CN109663148A (zh) * 2018-12-17 2019-04-23 太阳雨林（厦门）生物医药有限公司 一种细胞外基质高分子材料生物复合血管
WO2020227095A1 (en) 2019-05-03 2020-11-12 Lifecell Corporation Breast treatment device
US20210008106A1 (en) 2019-06-18 2021-01-14 United Therapeutics Corporation Mitochondrial treatment of organs for transplantation
CN111100838B (zh) * 2019-12-27 2023-05-09 广东博溪生物科技有限公司 低温保存运输培养基
WO2021154845A1 (en) 2020-01-27 2021-08-05 Geniphys, Llc Biologic filler for restoring and regenerating tissue
US20230357684A1 (en) * 2020-09-18 2023-11-09 University Of Virginia Patent Foundation 3d-printed modular microchip with an integrated impeller pump to model inter-organ communication
EP4565681A1 (de) * 2022-08-05 2025-06-11 The Texas A&M University System Hergestellte manipulierte hauthautzusammensetzungen und verfahren dafür
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型，及其制备方法和用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
DE3317550C2 (de) 1983-05-13 1985-08-22 Stephan Priv.Doz.Dr.rer.nat.Dr.med.habil. 8000 München Nees Verfahren zum Züchten einer lückenlosen Zellschicht und Vorrichtung zur Durchführung dieses Verfahrens
US5484432A (en) * 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US5026649A (en) 1986-03-20 1991-06-25 Costar Corporation Apparatus for growing tissue cultures in vitro
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5510254A (en) 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
JPS6410983A (en) * 1987-02-19 1989-01-13 Takeda Chemical Industries Ltd Artificial tissue and production thereof
EP0282746A1 (de) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Methode zur Herstellung von künstlichem Gewebe
FR2612939B1 (fr) 1987-03-26 1989-06-23 Cird Equivalent de peau
US4835102A (en) 1987-03-31 1989-05-30 Eugene Bell Tissue equivalent test systems
JPH051280Y2 (de) 1987-10-12 1993-01-13
IL94611A (en) 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
IL95429A (en) * 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
US5800537A (en) 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5374515A (en) 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5366893A (en) 1993-01-13 1994-11-22 Becton, Dickinson And Company Culture vessel
JPH07178A (ja) * 1993-06-11 1995-01-06 New Japan Chem Co Ltd 細胞培養用担体
US5891617A (en) 1993-09-15 1999-04-06 Organogenesis Inc. Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5763255A (en) * 1994-04-25 1998-06-09 Becton Dickinson And Company Inducing epithelial cell differentiation with dried native fibrillar collagen
CA2189421A1 (en) * 1994-05-11 1995-11-23 Peter K. Mays Collagen from cell cultures
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5618718A (en) 1994-12-30 1997-04-08 Universite Laval Production of a contractile smooth muscle
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5665391A (en) * 1995-10-12 1997-09-09 Spectral Diagnostics Inc. Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes
US5689961A (en) 1996-01-30 1997-11-25 Organogenesis Inc. Ice seeding apparatus for cryopreservation systems
US5766937A (en) 1996-02-15 1998-06-16 Becton Dickinson And Company Culture vessel and assembly
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
CA2351396C (en) * 1998-11-19 2012-08-14 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them
US6733530B1 (en) * 1999-08-02 2004-05-11 Eric Sun-Yin Chan Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin
CN100345452C (zh) * 2003-10-16 2007-10-24 华为技术有限公司 一种确定移动通信系统中用于加密同步的计数器检查发起时机的方法

Also Published As

Publication number Publication date
BR9915476A (pt) 2002-01-02
ATE305967T1 (de) 2005-10-15
JP2002530069A (ja) 2002-09-17
AU2010201787B2 (en) 2012-09-13
CA2351396A1 (en) 2000-05-25
CA2351396C (en) 2012-08-14
US7824913B2 (en) 2010-11-02
EP2295540A1 (de) 2011-03-16
ES2402739T3 (es) 2013-05-08
EP1612265B1 (de) 2013-01-16
US20080108134A1 (en) 2008-05-08
US20020172705A1 (en) 2002-11-21
DE69927600T2 (de) 2006-07-06
CN102051343A (zh) 2011-05-11
AU2004201787A1 (en) 2004-05-27
EP1131410B1 (de) 2005-10-05
CN1333818A (zh) 2002-01-30
AU2010201787A1 (en) 2010-05-27
HK1040740A1 (zh) 2002-06-21
WO2000029553A9 (en) 2000-11-09
AU769637B2 (en) 2004-01-29
WO2000029553A1 (en) 2000-05-25
JP5484975B2 (ja) 2014-05-07
DK1131410T3 (da) 2005-10-31
EP1612265A3 (de) 2006-03-01
EP1612265A2 (de) 2006-01-04
AU1917100A (en) 2000-06-05
EP1131410A1 (de) 2001-09-12
ES2249928T3 (es) 2006-04-01
IL143243A0 (en) 2002-04-21
JP2010187680A (ja) 2010-09-02
PT1612265E (pt) 2013-03-14

Similar Documents

Publication Publication Date Title
DE69927600D1 (de) Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung
DE69417011D1 (de) Verfahren zur herstellung von kathoden komponenten und zu ihrer verwendung in elektrochemischen zellen
ATE295899T1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
ATE234291T1 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
DE69721021D1 (de) Blasenmukosa mit zellen für die rekonstruktion von geweben
DE122007000082I1 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
ATE473228T1 (de) 5,6-dialkyl-7-aminotriazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
DE69724275D1 (de) Biopolymerschäume zur gewebeerneurung und -rekonstruktion
DE50015883D1 (de) Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie
DE69937411D1 (de) Klebstoffe auf basis von polyharnstoff, gegenstände davon, und verfahren zu ihrer herstellung und verwendung
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
DE69430059D1 (de) Freisetzung und Mobilisierung hämatopoietischer Zellen
DE59003581D1 (de) Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung.
WO2007103865A3 (en) Oral tissue regeneration and repair
DE59910532D1 (de) Flüssige stoffgemische und (co)polymerisate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von reaktiven mehrstoffmischungen
ATE335808T1 (de) Herstellung von zellsuspensionen
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
ATE211482T1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
DE59010759D1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE60132079D1 (de) Verfahren zur herstellung von bandersatzkonstruktionen
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
ATE430314T1 (de) Verfahren und mittel zur beeinflussung von interzellulärer kommunikation und interzellulärem organellentransport
DE69333962D1 (de) Modifizierte zellen auf der basis des betain-katabolismus, herstellung und verwendung insbesondere zur herstellung von metaboliten oder enzymen
EP1330267A4 (de) Zellkulturen olfaktorischer neurone und methoden zu deren herstellung und verwendung(22.01.02)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition